A detailed history of Rockefeller Capital Management L.P. transactions in Nkarta, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 4,166 shares of NKTX stock, worth $7,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,166
Holding current value
$7,790
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.67 - $2.37 $6,957 - $9,873
4,166 New
4,166 $8,000
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $7,770 - $19,440
1,000 New
1,000 $12,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $91M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.